Consolidated Financial Statements and Consolidated Directors' Report

Report overview

The report presents PharmaMar Group's 2024 consolidated financial and sustainability information, prepared under ESRS and subject to KPMG limited assurance. It reports validated Scope 1, 2 and 3 reduction targets, including a 2050 net-zero target, alongside detailed energy, GHG, water, waste and workforce metrics. The report also describes double-materiality assessment, Board sustainability oversight and EU Taxonomy disclosures.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status

Assurance

Provider
Level
Standard
Scope
Statement included

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Scope 2 emissions
Scope 3 emissions
Energy consumption
Renewable energy
Waste
Employees
Women on the board
Net zero target

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services